Silihan lan utang jangka dawa perusahaan cbdmd.com (YCBD)

cbdMD - logo grafis emiten YCBD

cbdMD, Inc. (YCBD) operates under stable conditions within the US domestic market, free from external risks. The price trend illustrated in this chart is accompanied by declining profitability due to a surplus of similar products and price wars. Meanwhile, the company is actively hiring digital marketers and brand managers, offering them performance-based bonuses. The current debt load stands at 0.00, which is critical for assessing the enterprise's stability.

YCBD cbdMD Inc.: Utang jangka dawa perusahaan ing interval 04.07.2022 - 28.10.2026
Produk sing diprodhuksi cbdmd.com

A stable cash flow from retail CBD product sales forms the financial foundation of cbdMD, Inc. (YCBD). An analysis of the organization's long-term financial debt tracks the total volume of credit obligations with a maturity of more than one year. This metric measures the leverage level, determining the business's dependence on borrowed capital. A decrease in this indicator confirms the effectiveness of management structure optimization. For the investor, the dynamics of these liabilities serve as an indicator of the balance between financial stability and the pace of expansion.

Analisis perusahaan pesaing

haleon.com - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan Kenvue (KVUE)|VRNA: Silihan lan utang jangka dawa perusahaan|MENS (Jyong Biotech Corp) - Utang jangka dawa perusahaan|Ligand Corp (LGND) - Kewajiban jangka dawa perusahaan|AMRX (Amneal Pharmaceuticals) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan perrigo.com (PRGO)|Alvotech SA (ALVO) - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan LQDA (Liquidia Corp)|GLPG: Utang jangka dawa perusahaan|ANIP - Utang jangka dawa|Kewajiban jangka dawa perusahaan MannKind Corporation MNKD|AMPH - Gedhene kewajiban jangka dawa|Utang jangka dawa perusahaan Pacira BioSciences, Inc. PCRX|ARS Pharmaceuticals Inc (SPRY) - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan TBPH (Theravance)|Utang jangka dawa AQST|scPharmaceuticals Inc. (SCPH) - Utang jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan tectonictx.com (TECX)|Tonix Pharmaceuticals Holding Corp. - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan SXT Pharmaceuticals SXTC|EPRX - Utang jangka dawa perusahaan|BHST - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan eXoZymes Inc|ORMP (Oramed Pharmaceuticals Inc.) - Tanggungan utang jangka dawa perusahaan|Utang jangka dawa perusahaan ENTX|Kewajiban jangka dawa perusahaan MindWalk Holdings, Inc.|Utang jangka dawa perusahaan ABVC BioPharma Inc ABVC|Tanggungan utang jangka dawa perusahaan Cumberland Corp CPIX|Kewajiban jangka dawa perusahaan Quantum BioPharma Ltd|Silihan lan utang jangka dawa perusahaan fibrogen.com FGEN|Utang jangka dawa perusahaan TELO (Telomir Pharmaceuticals, Inc.)|RANI: Gunggunge utang jangka dawa|Utang jangka dawa perusahaan synergychc.com|Rallybio (RLYB) - Tanggungan utang jangka dawa perusahaan|Utang jangka dawa perusahaan LEXX|Kewajiban jangka dawa perusahaan pulmatrix.com (PULM)|PTHL (Pheton Holdings Ltd) - Kewajiban jangka dawa perusahaan|Gunggunge utang jangka dawa aptorumgroup.com APM|LYRA: Kewajiban jangka dawa perusahaan|Utang jangka dawa impactbiomedinc.com IBO|TNFA: Utang jangka dawa perusahaan|PRFX - Kewajiban jangka dawa perusahaan|altamiratherapeutics.com (CYTO) - Utang jangka dawa perusahaan|Lipella Pharmaceuticals Inc (LIPO) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan Optinose (OPTN)|Tanggungan utang jangka dawa perusahaan PIRS|PROC - Utang jangka dawa perusahaan|Kewajiban jangka dawa petrospharma.com (PTPI)|Utang jangka dawa perusahaan Qilian International Holding|Silihan lan utang jangka dawa perusahaan Acelyrin Inc. SLRN|TFF Pharma - Utang jangka dawa perusahaan